Articles tagged with Chemokine Receptors
Researchers uncover CXCR4's role in suppressing aldosterone production by upregulating ID3, a transcription regulator that halts CYP11B2 expression. This novel signaling axis offers a new strategy to combat autonomous hormonal overproduction and severe secondary hypertension.
A new study maps the impact of stressors during pregnancy on the developing fetal brain, revealing a cell atlas and identifying key immune pathways. The research sheds light on how maternal gut-immune disruptions can shape neurodevelopmental disorders in children.
Researchers discovered blocking CCR1 increases glucocorticoid sensitivity in multiple myeloma cells, offering a new strategy to improve treatment outcomes. The study found that high levels of CCR1 are linked to worse outcomes and plays a critical role in drug resistance.
Researchers found that severe herpesvirus infections can strongly activate host cellular immunity, leading to a therapeutic effect on refractory adult T-cell leukemia/lymphoma. This activation may play an important role in the survival of patients with this intractable disease.
A new molecular imaging radiotracer, <sup> 68 </sup> Ga-PentixaFor, demonstrates high image contrast in various cancers, including hematologic malignancies and small cell lung cancer. This agent targets the C-X-C motif chemokine receptor 4 (CXCR4), which is a predictor of poor prognosis in cancer patients.
Researchers discovered a molecule involved in immune cell migration that plays a critical role in establishing immune responses. The COMMD3/8 complex promotes signal transduction of chemokine receptors to facilitate immune cell migration, which is essential for efficient immune responses and proper functioning of the immune system.
Scientists at the University of Adelaide have identified a key protein, CCR2, involved in a 'super-inflammatory' immune response driving multiple sclerosis (MS) and autoimmune diseases. Blocking this receptor may help control MS progression.
Wayne State University has secured a $1.9 million NIH grant to study the role of chemokine receptor CXCR2 in regulating new blood vessel formation and enhancing endothelial progenitor cells (EPCs)-based cell therapy for vascular diseases.
Researchers successfully silenced chemokine receptor 4 in SH-SY5Y cells, inhibiting neuroblastoma cell invasion. This approach may provide a new therapeutic strategy for blocking neuroblastoma metastasis.
A dysfunctional chemokine receptor, CXCR1, plays a crucial role in Candida infection progression. Mice lacking this receptor are prone to kidney failure due to Candida-induced injury. Additionally, patients with a mutation in the CXCR1 gene are at higher risk of developing candidiasis.
A Northwestern University study found that women with sexually transmitted diseases or elevated progesterone levels are more susceptible to HIV infection after unprotected sex with an HIV-positive partner. The research suggests that blocking chemokine receptors in genital tissues could be a key strategy for preventing male-to-female HI...
Researchers have identified key chemokine receptors that enable HIV to infect immune system cells, including CCR5 and CCR-3. Understanding these interactions could lead to the development of new treatments and prevention strategies for HIV/AIDS.